nodes	percent_of_prediction	percent_of_DWPC	metapath
Adefovir Dipivoxil—ABCC5—Cisplatin—bone cancer	0.466	0.609	CbGbCtD
Adefovir Dipivoxil—ABCC4—Methotrexate—bone cancer	0.145	0.19	CbGbCtD
Adefovir Dipivoxil—SLC22A8—Methotrexate—bone cancer	0.0909	0.119	CbGbCtD
Adefovir Dipivoxil—SLC22A6—Methotrexate—bone cancer	0.0633	0.0826	CbGbCtD
Adefovir Dipivoxil—Renal tubular disorder—Cisplatin—bone cancer	0.0137	0.0999	CcSEcCtD
Adefovir Dipivoxil—AK2—Nucleotide metabolism—NT5C3A—bone cancer	0.0102	0.105	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide Metabolism—DHFR—bone cancer	0.00885	0.0915	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Nucleotide metabolism—NT5C3A—bone cancer	0.00704	0.0727	CbGpPWpGaD
Adefovir Dipivoxil—Nephrotoxicity—Cisplatin—bone cancer	0.00626	0.0456	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—BMI1—bone cancer	0.00542	0.056	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Nucleotide metabolism—NT5C3A—bone cancer	0.00533	0.0551	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—BMI1—bone cancer	0.00411	0.0424	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.00398	0.0411	CbGpPWpGaD
Adefovir Dipivoxil—Nephropathy toxic—Cisplatin—bone cancer	0.00347	0.0252	CcSEcCtD
Adefovir Dipivoxil—Hypophosphataemia—Cisplatin—bone cancer	0.00343	0.0249	CcSEcCtD
Adefovir Dipivoxil—Serum creatinine increased—Cisplatin—bone cancer	0.00324	0.0236	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—EIF2S1—bone cancer	0.00303	0.0313	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—DHFR—bone cancer	0.00233	0.0241	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Drug Induction of Bile Acid Pathway—CYP3A4—bone cancer	0.00233	0.024	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—EIF2S1—bone cancer	0.0023	0.0237	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—IGF1R—bone cancer	0.00218	0.0225	CbGpPWpGaD
Adefovir Dipivoxil—Kidney function abnormal—Epirubicin—bone cancer	0.00212	0.0154	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Cisplatin—bone cancer	0.00199	0.0145	CcSEcCtD
Adefovir Dipivoxil—Kidney function abnormal—Doxorubicin—bone cancer	0.00196	0.0143	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Cisplatin—bone cancer	0.00196	0.0142	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Carboplatin—bone cancer	0.00192	0.0139	CcSEcCtD
Adefovir Dipivoxil—Fracture—Methotrexate—bone cancer	0.00188	0.0137	CcSEcCtD
Adefovir Dipivoxil—Multiple fractures—Methotrexate—bone cancer	0.00188	0.0137	CcSEcCtD
Adefovir Dipivoxil—Hypophosphataemia—Epirubicin—bone cancer	0.00176	0.0128	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—MET—bone cancer	0.00168	0.0173	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Ectoderm Differentiation—BCOR—bone cancer	0.00167	0.0172	CbGpPWpGaD
Adefovir Dipivoxil—Serum creatinine increased—Epirubicin—bone cancer	0.00166	0.0121	CcSEcCtD
Adefovir Dipivoxil—Hypophosphataemia—Doxorubicin—bone cancer	0.00163	0.0119	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—DHFR—bone cancer	0.00161	0.0167	CbGpPWpGaD
Adefovir Dipivoxil—Liver disorder—Methotrexate—bone cancer	0.0016	0.0117	CcSEcCtD
Adefovir Dipivoxil—Serum creatinine increased—Doxorubicin—bone cancer	0.00154	0.0112	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—CDK4—bone cancer	0.00149	0.0154	CbGpPWpGaD
Adefovir Dipivoxil—Blood creatinine increased—Cisplatin—bone cancer	0.00135	0.00986	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00127	0.0131	CbGpPWpGaD
Adefovir Dipivoxil—Glycosuria—Epirubicin—bone cancer	0.00126	0.00919	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Cisplatin—bone cancer	0.00123	0.00892	CcSEcCtD
Adefovir Dipivoxil—Glycosuria—Doxorubicin—bone cancer	0.00117	0.0085	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—CDK4—bone cancer	0.00113	0.0116	CbGpPWpGaD
Adefovir Dipivoxil—Cough increased—Epirubicin—bone cancer	0.00112	0.00813	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—NDUFA12—bone cancer	0.00111	0.0115	CbGpPWpGaD
Adefovir Dipivoxil—Renal failure—Cisplatin—bone cancer	0.0011	0.00797	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00108	0.0112	CbGpPWpGaD
Adefovir Dipivoxil—Creatinine increased—Epirubicin—bone cancer	0.00107	0.00782	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Epirubicin—bone cancer	0.00107	0.00777	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Cisplatin—bone cancer	0.00105	0.00767	CcSEcCtD
Adefovir Dipivoxil—Cough increased—Doxorubicin—bone cancer	0.00103	0.00753	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Epirubicin—bone cancer	0.00102	0.00745	CcSEcCtD
Adefovir Dipivoxil—Hyperkalaemia—Epirubicin—bone cancer	0.001	0.00732	CcSEcCtD
Adefovir Dipivoxil—Creatinine increased—Doxorubicin—bone cancer	0.000994	0.00724	CcSEcCtD
Adefovir Dipivoxil—Bone pain—Doxorubicin—bone cancer	0.000988	0.00719	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Cisplatin—bone cancer	0.000988	0.00719	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000985	0.0102	CbGpPWpGaD
Adefovir Dipivoxil—Connective tissue disorder—Cisplatin—bone cancer	0.000983	0.00716	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Cisplatin—bone cancer	0.000981	0.00714	CcSEcCtD
Adefovir Dipivoxil—Hepatocellular injury—Doxorubicin—bone cancer	0.000946	0.00689	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—MMP9—bone cancer	0.000932	0.00963	CbGpPWpGaD
Adefovir Dipivoxil—Hyperkalaemia—Doxorubicin—bone cancer	0.00093	0.00677	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—NT5C3A—bone cancer	0.000923	0.00953	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000897	0.00927	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000885	0.00914	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic failure—Methotrexate—bone cancer	0.000883	0.00643	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Cisplatin—bone cancer	0.000871	0.00634	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Cisplatin—bone cancer	0.000858	0.00625	CcSEcCtD
Adefovir Dipivoxil—NME1—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—bone cancer	0.000851	0.00879	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic function abnormal—Epirubicin—bone cancer	0.00085	0.00618	CcSEcCtD
Adefovir Dipivoxil—Hepatic failure—Epirubicin—bone cancer	0.000826	0.00601	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet degranulation—SPARC—bone cancer	0.000813	0.00839	CbGpPWpGaD
Adefovir Dipivoxil—Anaemia—Cisplatin—bone cancer	0.000805	0.00586	CcSEcCtD
Adefovir Dipivoxil—Hepatic function abnormal—Doxorubicin—bone cancer	0.000786	0.00572	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Epirubicin—bone cancer	0.00078	0.00568	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Response to elevated platelet cytosolic Ca2+—SPARC—bone cancer	0.000774	0.008	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—NDUFA12—bone cancer	0.000772	0.00797	CbGpPWpGaD
Adefovir Dipivoxil—Hepatic failure—Doxorubicin—bone cancer	0.000764	0.00556	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00075	0.00775	CbGpPWpGaD
Adefovir Dipivoxil—Myalgia—Cisplatin—bone cancer	0.000741	0.0054	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000736	0.00536	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Methotrexate—bone cancer	0.000733	0.00533	CcSEcCtD
Adefovir Dipivoxil—Renal impairment—Doxorubicin—bone cancer	0.000722	0.00525	CcSEcCtD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—MMP9—bone cancer	0.000707	0.0073	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Cisplatin—bone cancer	0.000697	0.00507	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Cisplatin—bone cancer	0.000696	0.00506	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Epirubicin—bone cancer	0.000696	0.00506	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Cisplatin—bone cancer	0.00069	0.00502	CcSEcCtD
Adefovir Dipivoxil—Liver function test abnormal—Epirubicin—bone cancer	0.000686	0.00499	CcSEcCtD
Adefovir Dipivoxil—Anorexia—Cisplatin—bone cancer	0.000677	0.00493	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Methotrexate—bone cancer	0.000672	0.00489	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Epirubicin—bone cancer	0.000655	0.00477	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000647	0.00471	CcSEcCtD
Adefovir Dipivoxil—Blood creatinine increased—Doxorubicin—bone cancer	0.000644	0.00469	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—NT5C3A—bone cancer	0.000639	0.00661	CbGpPWpGaD
Adefovir Dipivoxil—Liver function test abnormal—Doxorubicin—bone cancer	0.000634	0.00462	CcSEcCtD
Adefovir Dipivoxil—NME2—Validated targets of C-MYC transcriptional activation—TP53—bone cancer	0.000633	0.00654	CbGpPWpGaD
Adefovir Dipivoxil—Pancreatitis—Epirubicin—bone cancer	0.000629	0.00458	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Cisplatin—bone cancer	0.000618	0.0045	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Cisplatin—bone cancer	0.000614	0.00447	CcSEcCtD
Adefovir Dipivoxil—Alanine aminotransferase increased—Doxorubicin—bone cancer	0.000606	0.00441	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Methotrexate—bone cancer	0.000601	0.00438	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—NDUFA12—bone cancer	0.000585	0.00604	CbGpPWpGaD
Adefovir Dipivoxil—Haematuria—Methotrexate—bone cancer	0.000583	0.00424	CcSEcCtD
Adefovir Dipivoxil—Pancreatitis—Doxorubicin—bone cancer	0.000582	0.00424	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Epirubicin—bone cancer	0.000581	0.00423	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Methotrexate—bone cancer	0.000578	0.00421	CcSEcCtD
Adefovir Dipivoxil—Renal failure—Epirubicin—bone cancer	0.000562	0.00409	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Cisplatin—bone cancer	0.000562	0.00409	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Epirubicin—bone cancer	0.000558	0.00406	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000556	0.00575	CbGpPWpGaD
Adefovir Dipivoxil—Hepatitis—Methotrexate—bone cancer	0.000549	0.004	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Epirubicin—bone cancer	0.000546	0.00397	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Methotrexate—bone cancer	0.000545	0.00397	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Methotrexate—bone cancer	0.000542	0.00395	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Epirubicin—bone cancer	0.000541	0.00394	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Methotrexate—bone cancer	0.000538	0.00392	CcSEcCtD
Adefovir Dipivoxil—Weight decreased—Doxorubicin—bone cancer	0.000537	0.00391	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Epirubicin—bone cancer	0.000537	0.00391	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Fluoropyrimidine Activity—TP53—bone cancer	0.000521	0.00538	CbGpPWpGaD
Adefovir Dipivoxil—Renal failure—Doxorubicin—bone cancer	0.00052	0.00379	CcSEcCtD
Adefovir Dipivoxil—Jaundice—Doxorubicin—bone cancer	0.000516	0.00376	CcSEcCtD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—TGFBR2—bone cancer	0.000514	0.00531	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—NRF2 pathway—GSTP1—bone cancer	0.000514	0.00531	CbGpPWpGaD
Adefovir Dipivoxil—Hepatitis—Epirubicin—bone cancer	0.000514	0.00374	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Cisplatin—bone cancer	0.00051	0.00371	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Epirubicin—bone cancer	0.00051	0.00371	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Epirubicin—bone cancer	0.000507	0.00369	CcSEcCtD
Adefovir Dipivoxil—Haematuria—Doxorubicin—bone cancer	0.000505	0.00367	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Epirubicin—bone cancer	0.000505	0.00367	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Epirubicin—bone cancer	0.000504	0.00367	CcSEcCtD
Adefovir Dipivoxil—Hepatobiliary disease—Doxorubicin—bone cancer	0.000501	0.00364	CcSEcCtD
Adefovir Dipivoxil—Sinusitis—Doxorubicin—bone cancer	0.000497	0.00362	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Cisplatin—bone cancer	0.000486	0.00354	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—NT5C3A—bone cancer	0.000485	0.00501	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Carbohydrate metabolism—ENO2—bone cancer	0.000483	0.00499	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Validated targets of C-MYC transcriptional activation—TP53—bone cancer	0.000479	0.00495	CbGpPWpGaD
Adefovir Dipivoxil—Malnutrition—Methotrexate—bone cancer	0.000478	0.00348	CcSEcCtD
Adefovir Dipivoxil—Hepatitis—Doxorubicin—bone cancer	0.000475	0.00346	CcSEcCtD
Adefovir Dipivoxil—Pharyngitis—Doxorubicin—bone cancer	0.000472	0.00343	CcSEcCtD
Adefovir Dipivoxil—Urinary tract disorder—Doxorubicin—bone cancer	0.000469	0.00342	CcSEcCtD
Adefovir Dipivoxil—Connective tissue disorder—Doxorubicin—bone cancer	0.000467	0.0034	CcSEcCtD
Adefovir Dipivoxil—Urethral disorder—Doxorubicin—bone cancer	0.000466	0.00339	CcSEcCtD
Adefovir Dipivoxil—Back pain—Methotrexate—bone cancer	0.000462	0.00336	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Cisplatin—bone cancer	0.000452	0.00329	CcSEcCtD
Adefovir Dipivoxil—Rash—Cisplatin—bone cancer	0.000448	0.00326	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Cisplatin—bone cancer	0.000448	0.00326	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Epirubicin—bone cancer	0.000447	0.00325	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Methotrexate—bone cancer	0.000442	0.00321	CcSEcCtD
Adefovir Dipivoxil—Flatulence—Epirubicin—bone cancer	0.000441	0.00321	CcSEcCtD
Adefovir Dipivoxil—Back pain—Epirubicin—bone cancer	0.000433	0.00315	CcSEcCtD
Adefovir Dipivoxil—Nausea—Cisplatin—bone cancer	0.000422	0.00307	CcSEcCtD
Adefovir Dipivoxil—Cough—Methotrexate—bone cancer	0.000417	0.00304	CcSEcCtD
Adefovir Dipivoxil—Malnutrition—Doxorubicin—bone cancer	0.000414	0.00301	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Epirubicin—bone cancer	0.000413	0.00301	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000412	0.00426	CbGpPWpGaD
Adefovir Dipivoxil—Flatulence—Doxorubicin—bone cancer	0.000408	0.00297	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Methotrexate—bone cancer	0.000407	0.00296	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Methotrexate—bone cancer	0.000407	0.00296	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—ENO2—bone cancer	0.000404	0.00417	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000404	0.00294	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000404	0.00417	CbGpPWpGaD
Adefovir Dipivoxil—Back pain—Doxorubicin—bone cancer	0.0004	0.00291	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000398	0.00411	CbGpPWpGaD
Adefovir Dipivoxil—Cough—Epirubicin—bone cancer	0.00039	0.00284	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Methotrexate—bone cancer	0.000382	0.00278	CcSEcCtD
Adefovir Dipivoxil—Anaemia—Doxorubicin—bone cancer	0.000382	0.00278	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Methotrexate—bone cancer	0.000382	0.00278	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Epirubicin—bone cancer	0.000381	0.00277	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Epirubicin—bone cancer	0.000381	0.00277	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Methotrexate—bone cancer	0.000379	0.00276	CcSEcCtD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000378	0.00275	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—DHFR—bone cancer	0.000375	0.00387	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Methotrexate—bone cancer	0.000372	0.00271	CcSEcCtD
Adefovir Dipivoxil—Cough—Doxorubicin—bone cancer	0.000361	0.00263	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Fluoropyrimidine Activity—TP53—bone cancer	0.000361	0.00373	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.00036	0.00372	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000358	0.0037	CbGpPWpGaD
Adefovir Dipivoxil—Nervous system disorder—Epirubicin—bone cancer	0.000358	0.00261	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Epirubicin—bone cancer	0.000357	0.0026	CcSEcCtD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—GSTP1—bone cancer	0.000356	0.00368	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—NRF2 pathway—TGFBR2—bone cancer	0.000356	0.00368	CbGpPWpGaD
Adefovir Dipivoxil—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000355	0.00259	CcSEcCtD
Adefovir Dipivoxil—Skin disorder—Epirubicin—bone cancer	0.000354	0.00258	CcSEcCtD
Adefovir Dipivoxil—Chest pain—Doxorubicin—bone cancer	0.000352	0.00256	CcSEcCtD
Adefovir Dipivoxil—Myalgia—Doxorubicin—bone cancer	0.000352	0.00256	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GNA11—bone cancer	0.00035	0.00362	CbGpPWpGaD
Adefovir Dipivoxil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.00035	0.00255	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000349	0.0036	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Epirubicin—bone cancer	0.000348	0.00253	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Methotrexate—bone cancer	0.000343	0.0025	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Methotrexate—bone cancer	0.000339	0.00247	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal disorder—Methotrexate—bone cancer	0.000337	0.00245	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000332	0.00242	CcSEcCtD
Adefovir Dipivoxil—Nervous system disorder—Doxorubicin—bone cancer	0.000331	0.00241	CcSEcCtD
Adefovir Dipivoxil—Thrombocytopenia—Doxorubicin—bone cancer	0.000331	0.00241	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.00033	0.00341	CbGpPWpGaD
Adefovir Dipivoxil—Skin disorder—Doxorubicin—bone cancer	0.000328	0.00239	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000324	0.00335	CbGpPWpGaD
Adefovir Dipivoxil—Anorexia—Doxorubicin—bone cancer	0.000322	0.00234	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Epirubicin—bone cancer	0.000321	0.00234	CcSEcCtD
Adefovir Dipivoxil—Gastrointestinal pain—Methotrexate—bone cancer	0.000319	0.00232	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—CYP3A4—bone cancer	0.000318	0.00328	CbGpPWpGaD
Adefovir Dipivoxil—Decreased appetite—Epirubicin—bone cancer	0.000317	0.00231	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—NDUFA12—bone cancer	0.000316	0.00326	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Epirubicin—bone cancer	0.000315	0.00229	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Methotrexate—bone cancer	0.000308	0.00224	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Methotrexate—bone cancer	0.000308	0.00224	CcSEcCtD
Adefovir Dipivoxil—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000308	0.00224	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000299	0.00309	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Epirubicin—bone cancer	0.000298	0.00217	CcSEcCtD
Adefovir Dipivoxil—Dyspepsia—Doxorubicin—bone cancer	0.000297	0.00216	CcSEcCtD
Adefovir Dipivoxil—Decreased appetite—Doxorubicin—bone cancer	0.000294	0.00214	CcSEcCtD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000292	0.00302	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000292	0.00212	CcSEcCtD
Adefovir Dipivoxil—Body temperature increased—Epirubicin—bone cancer	0.000288	0.0021	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Epirubicin—bone cancer	0.000288	0.0021	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000282	0.00291	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—ENO2—bone cancer	0.00028	0.00289	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.00028	0.00289	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Methotrexate—bone cancer	0.00028	0.00204	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00028	0.00289	CbGpPWpGaD
Adefovir Dipivoxil—Gastrointestinal pain—Doxorubicin—bone cancer	0.000276	0.00201	CcSEcCtD
Adefovir Dipivoxil—Pruritus—Methotrexate—bone cancer	0.000276	0.00201	CcSEcCtD
Adefovir Dipivoxil—AK2—Metabolism—GSTP1—bone cancer	0.000272	0.00281	CbGpPWpGaD
Adefovir Dipivoxil—Body temperature increased—Doxorubicin—bone cancer	0.000267	0.00194	CcSEcCtD
Adefovir Dipivoxil—Abdominal pain—Doxorubicin—bone cancer	0.000267	0.00194	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Methotrexate—bone cancer	0.000267	0.00194	CcSEcCtD
Adefovir Dipivoxil—Asthenia—Epirubicin—bone cancer	0.000262	0.00191	CcSEcCtD
Adefovir Dipivoxil—ABCC5—Metabolism—NT5C3A—bone cancer	0.000262	0.0027	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—DHFR—bone cancer	0.00026	0.00268	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Epirubicin—bone cancer	0.000258	0.00188	CcSEcCtD
Adefovir Dipivoxil—SLC22A3—Metabolism—NDUFA12—bone cancer	0.000253	0.00262	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A8—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000252	0.0026	CbGpPWpGaD
Adefovir Dipivoxil—Diarrhoea—Epirubicin—bone cancer	0.00025	0.00182	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Methotrexate—bone cancer	0.000248	0.0018	CcSEcCtD
Adefovir Dipivoxil—Rash—Methotrexate—bone cancer	0.000246	0.00179	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Methotrexate—bone cancer	0.000246	0.00179	CcSEcCtD
Adefovir Dipivoxil—Headache—Methotrexate—bone cancer	0.000244	0.00178	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—TUBB4B—bone cancer	0.000244	0.00252	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GNA11—bone cancer	0.000243	0.00251	CbGpPWpGaD
Adefovir Dipivoxil—Asthenia—Doxorubicin—bone cancer	0.000242	0.00176	CcSEcCtD
Adefovir Dipivoxil—ABCC4—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000242	0.0025	CbGpPWpGaD
Adefovir Dipivoxil—Pruritus—Doxorubicin—bone cancer	0.000239	0.00174	CcSEcCtD
Adefovir Dipivoxil—NME1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000237	0.00244	CbGpPWpGaD
Adefovir Dipivoxil—Vomiting—Epirubicin—bone cancer	0.000232	0.00169	CcSEcCtD
Adefovir Dipivoxil—Nausea—Methotrexate—bone cancer	0.000232	0.00169	CcSEcCtD
Adefovir Dipivoxil—Diarrhoea—Doxorubicin—bone cancer	0.000231	0.00168	CcSEcCtD
Adefovir Dipivoxil—Rash—Epirubicin—bone cancer	0.00023	0.00167	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Epirubicin—bone cancer	0.00023	0.00167	CcSEcCtD
Adefovir Dipivoxil—Headache—Epirubicin—bone cancer	0.000229	0.00166	CcSEcCtD
Adefovir Dipivoxil—NME2—Metabolism—CYP3A4—bone cancer	0.00022	0.00227	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Epirubicin—bone cancer	0.000217	0.00158	CcSEcCtD
Adefovir Dipivoxil—Vomiting—Doxorubicin—bone cancer	0.000215	0.00156	CcSEcCtD
Adefovir Dipivoxil—Rash—Doxorubicin—bone cancer	0.000213	0.00155	CcSEcCtD
Adefovir Dipivoxil—Dermatitis—Doxorubicin—bone cancer	0.000213	0.00155	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—ENO2—bone cancer	0.000212	0.00219	CbGpPWpGaD
Adefovir Dipivoxil—Headache—Doxorubicin—bone cancer	0.000212	0.00154	CcSEcCtD
Adefovir Dipivoxil—SLC22A6—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.00021	0.00217	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—NT5C3A—bone cancer	0.00021	0.00217	CbGpPWpGaD
Adefovir Dipivoxil—Nausea—Doxorubicin—bone cancer	0.000201	0.00146	CcSEcCtD
Adefovir Dipivoxil—NME1—Metabolism—DHFR—bone cancer	0.000197	0.00203	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—GSTP1—bone cancer	0.000188	0.00195	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—SPARC—bone cancer	0.000186	0.00192	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GNA11—bone cancer	0.000184	0.0019	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—GNA11—bone cancer	0.00017	0.00176	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—CYP3A4—bone cancer	0.000167	0.00172	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—IL3—bone cancer	0.000154	0.00159	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—GSTP1—bone cancer	0.000143	0.00147	CbGpPWpGaD
Adefovir Dipivoxil—AK2—Metabolism—PTGS2—bone cancer	0.000141	0.00145	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—ENO2—bone cancer	0.000137	0.00141	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—DHFR—bone cancer	0.000127	0.00131	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—ENO2—bone cancer	0.000115	0.00118	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—DHFR—bone cancer	0.000106	0.0011	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—PLAU—bone cancer	0.000101	0.00104	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GNA11—bone cancer	9.94e-05	0.00103	CbGpPWpGaD
Adefovir Dipivoxil—NME2—Metabolism—PTGS2—bone cancer	9.76e-05	0.00101	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—TGFBR2—bone cancer	9.2e-05	0.000951	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—ENO2—bone cancer	9.19e-05	0.00095	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—CYP3A4—bone cancer	9.01e-05	0.000931	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—DHFR—bone cancer	8.53e-05	0.000881	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GNA11—bone cancer	7.97e-05	0.000823	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—GSTP1—bone cancer	7.71e-05	0.000796	CbGpPWpGaD
Adefovir Dipivoxil—NME1—Metabolism—PTGS2—bone cancer	7.39e-05	0.000764	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—CYP3A4—bone cancer	7.23e-05	0.000747	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—KIT—bone cancer	6.28e-05	0.000649	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—GSTP1—bone cancer	6.18e-05	0.000639	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—BRAF—bone cancer	5.9e-05	0.00061	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—MDM2—bone cancer	4.95e-05	0.000511	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—PTGS2—bone cancer	4.77e-05	0.000492	CbGpPWpGaD
Adefovir Dipivoxil—ABCC4—Hemostasis—TP53—bone cancer	4.06e-05	0.00042	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Metabolism—PTGS2—bone cancer	3.99e-05	0.000412	CbGpPWpGaD
Adefovir Dipivoxil—ABCC5—Disease—EGFR—bone cancer	3.38e-05	0.000349	CbGpPWpGaD
Adefovir Dipivoxil—SLC22A3—Metabolism—PTGS2—bone cancer	3.2e-05	0.000331	CbGpPWpGaD
